ライフサイエンスコーパス: neonatal death

1 cases of pSBI diagnosed for each associated neonatal death.

2 Cs results in severe mid-facial clefting and neonatal death.

3 weight for gestational age), stillbirth, and neonatal death.

4 a CI subunit, cause severe CI deficiency and neonatal death.

5 severe microcephaly, small somatic size, and neonatal death.

6 y impaired inspiratory rhythm and pronounced neonatal death.

7 a is associated with increased risk of early neonatal death.

8 rity are amongst the strongest predictors of neonatal death.

9 ion, 0.252-0.552) were the leading causes of neonatal death.

10 D die as a TOFPA, late fetal death, or early neonatal death.

11 lting in incomplete villus morphogenesis and neonatal death.

12 reterm birth, low birth weight, and fetal or neonatal death.

13 ated with an increased risk of stillbirth or neonatal death.

14 nd lens degeneration, brain hemorrhages, and neonatal death.

15 racic cavity, leading to lung hypoplasia and neonatal death.

16 , hindbrain, and inner ear deficiencies, and neonatal death.

17 demia, which is sufficiently severe to cause neonatal death.

18 k for preterm birth, very preterm birth, and neonatal death.

19 ported that homozygous (MTPa-/-) mice suffer neonatal death.

20 and its ablation results in exencephaly and neonatal death.

21 ng of some breeding pairs, renal failure and neonatal death.

22 however, dramatic neurodegeneration leads to neonatal death.

23 been shown to cause severe dwarfism but not neonatal death.

24 e embryo growth retardation, fetal loss, and neonatal death.

25 and physical disabilities and often leads to neonatal death.

26 opathy, hepatic lipid accumulation and early neonatal death.

27 e LPL did not rescue LPL knock-out mice from neonatal death.

28 1 gene have delayed parturition resulting in neonatal death.

29 exclusively in liver rescued LPL0 mice from neonatal death.

30 eted allele exhibit similar deficiencies and neonatal death.

31 mphocyte development and a high frequency of neonatal death.

32 the genetic basis of severe microcephaly and neonatal death.

33 defined as the combination of stillbirth and neonatal death.

34 estational age, miscarriage, stillbirth, and neonatal death.

35 rative skin conditions and for stillbirth or neonatal death.

36 oxygen supplementation necessary to prevent neonatal death.

37 s in altered epithelial cell homeostasis and neonatal death.

38 ultiorgan pathologies, vascular defects, and neonatal death.

39 l abnormalities, seven stillbirths, and nine neonatal deaths.

40 munity care at 90% coverage averts 18-37% of neonatal deaths.

41 uld provide a cost-effective way of reducing neonatal deaths.

42 undergoing a trial of labor), including two neonatal deaths.

43 tion, and a small group of causes leading to neonatal deaths.

44 PrP that otherwise cause many embryonic and neonatal deaths.

45 There were no neonatal deaths.

46 s, blindness, encephalitis, and occasionally neonatal deaths.

47 re a leading cause of the 2.9 million annual neonatal deaths.

48 lth surveys for information on the timing of neonatal deaths.

49 83% of all maternal deaths, stillbirths, and neonatal deaths.

50 w birth weight (0.68; .29-1.57) and fetal or neonatal death (0.24; .04-1.52).

51 1.4%), intrauterine fetal demise (2.8%), and neonatal death (1.4%).

52 tal interventions by 2025 could avert 71% of neonatal deaths (1.9 million [range 1.6-2.1 million]), 3

53 1.00-1.35; I2 = 93.7%; n = 11 studies); for neonatal death, 1.15 (95% CI, 1.07-1.23; I2 = 78.5%; n =

54 y between groups (six [2.0%] vs three [1.0%] neonatal deaths; 1.0, -1.04 to 2.97; p=0.322).

55 5% confidence interval (CI): 1.23, 4.17) for neonatal death, 2.44 (95% CI: 1.76, 3.37) for respirator

56 on deaths in 2010, consisting of 3.1 million neonatal deaths, 2.3 million postneonatal deaths, and 2.

57 (95% CI, 67-81), and 86 (95% CI, 76-98); for neonatal death, 20, 21 (95% CI, 19-23), and 24 (95% CI,

58 d RR of 359.4 (95% CI 277.3-465.9) for early neonatal death, 30.5 (18.0-51.6) for late neonatal death

59 %), 4 premature deliveries (3%), and 1 early neonatal death; 38 deliveries (36%) were by cesarean sec

60 0 early fetal deaths and stillbirths, 62 000 neonatal deaths, 44 000 preterm or low weight births, an

61 te outcome (105/408 [26%] vs 115/419 [27%]), neonatal death (47/449 [11%] vs 58/449 [13%]), severe IV

62 Thus, 67 000 maternal deaths, 440 000 neonatal deaths, 473 000 child deaths, and 564 000 still

63 participants; OR, 0.43; 95% CI, 0.19-0.99), neonatal death (5 studies, 374 participants; OR, 0.26; 9

64 ths (total about 290,000) and stillbirths or neonatal deaths (5.5 million) occur every year.

65 In eight of the 13 countries with the most neonatal deaths (55% worldwide), we undertook a systemat

66 In a Scotland-wide study of neonatal deaths, 70 brains have been examined.

67 CNS-specific knockout of Ufm1 in mice causes neonatal death accompanied by microcephaly and apoptosis

68 In 2013, neonatal deaths accounted for 41.6% of under-5 deaths co

69 tio [OR], 1.17; 95% CI, 0.96-1.41; P = .12), neonatal death (adjusted OR, 1.23; 95% CI, 0.96-1.57; P

70 ity was associated with an increased odds of neonatal death after adjustment for confounding factors

71 During the same period, the OR for neonatal death after preeclamptic pregnancy remained rel

72 Every year about 70% of neonatal deaths (almost 3 million) happen because effect

73 l age, very low birthweight, miscarriage, or neonatal death, although few data were available for the

74 lestasis (due to Abcb11 deficiency) produces neonatal death among all offspring within 24 h of birth

75 no reports of maternal death, stillbirth, or neonatal death among the donors.

76 Study (CCSS), of the risk of stillbirth and neonatal death among the offspring of men and women who

77 was a composite of intrapartum fetal death, neonatal death, an Apgar score of 3 or less at 5 minutes

78 Raf deletion caused neonatal death and a significant expansion of the hypert

79 The primary outcome was the composite of neonatal death and any of several adverse events, includ

80 neonatal hypoxia-ischemia, a major cause of neonatal death and pediatric disability.

81 ary neonatal composite outcome that included neonatal death and serious neonatal complications (14.3%

82 care for patients experiencing miscarriage, neonatal death and stillbirth as part of their work.

83 Sub-Saharan Africa had the highest risk of neonatal death and, therefore, had the highest risk of d

84 A quarter of the world's neonatal deaths and 15% of maternal deaths happen in Ind

85 Of the 3.7 million neonatal deaths and 3.3 million stillbirths each year, 9

86 ies do not get a birth certificate, and most neonatal deaths and almost all stillbirths have no death

87 However, less than 5% of neonatal deaths and even fewer stillbirths have death re

88 the biggest risk factor for more than 80% of neonatal deaths and increases risk of post-neonatal mort

89 tillbirth), and the secondary endpoints were neonatal deaths and malformations.

90 al homoplasmic mutation that resulted in six neonatal deaths and one surviving child with Leigh syndr

91 o meet Every Newborn targets of ten or fewer neonatal deaths and ten or fewer stillbirths per 1000 bi

92 nd pneumonia were not accelerated, causes of neonatal deaths and undernutrition were not addressed, a

93 Safety outcomes were deaths in utero and neonatal deaths and were assessed in all randomly alloca

94 wth restriction, which increases the risk of neonatal deaths and, for survivors, of stunting by 2 yea

95 ly neonatal death, 30.5 (18.0-51.6) for late neonatal death, and 50.2 (42.8-59.0) for infant death.

96 ted mothers on the end points of stillbirth, neonatal death, and congenital syphilis were obtained fr

97 onal-age infants, preterm birth, stillbirth, neonatal death, and major congenital malformations.

98 The risks of stillbirth, neonatal death, and perinatal death increased with the a

99 t smoking increases the risks of stillbirth, neonatal death, and perinatal death.

100 complications in labour carry a high risk of neonatal death, and poverty is strongly associated with

101 ernal deaths, 849 000 stillbirths, 1 498 000 neonatal deaths, and 1 515 000 additional child deaths.

102 ths, more than 4311 perinatal deaths, 11,294 neonatal deaths, and 4983 infant deaths were included.

103 of half a million maternal deaths, 4 million neonatal deaths, and 6 million child deaths.

104 um stillbirths, end preventable maternal and neonatal deaths, and improve child development.

105 We identified births, stillbirths, and neonatal deaths, and interviewed mothers 6 weeks after d

106 t encompassed eclampsia, preeclampsia, fetal/neonatal deaths, and small litter sizes occurred in some

107 risk of stillbirth, very preterm birth, and neonatal death; and ZDV-3TC-LPV-R was associated with hi

108 s in the study, 6054 were stillbirths; 3609, neonatal deaths; and 1578, postneonatal deaths.

109 aths, 531,000 stillbirths, and 1.325 million neonatal deaths annually by 2020 at an estimated running

110 ternal undernutrition contributes to 800,000 neonatal deaths annually through small for gestational a

111 many as 163 513 maternal deaths and 803 129 neonatal deaths annually.

112 revalence rate ratio [aPRR] 1.19, P = .8) or neonatal death (aPRR 0.68, P = .6).

113 Globally, the main direct causes of neonatal death are estimated to be preterm birth (28%),

114 ncluding the east African region, a third of neonatal deaths are due to infections.

115 Reducing maternal and neonatal deaths are important global health priorities.

116 The highest numbers of neonatal deaths are in south-central Asian countries and

117 Early neonatal deaths are sometimes under-reported or might be

118 Almost all (99%) neonatal deaths arise in low-income and middle-income co

119 ount for a quarter of the 2.8 million annual neonatal deaths, as well as approximately 3% of all disa

120 ic conditions, whereas the relative risk for neonatal death associated with maternal affective disord

121 on 2 families with a history of in utero and neonatal deaths associated with nonimmune hydrops fetali

122 ere 0.68 million (0.46 million-0.92 million) neonatal deaths associated with pSBI in 2012.

123 -two infants were born prematurely; with one neonatal death at 6 weeks.

124 gnificantly increased risk of stillbirth and neonatal death at doses greater than 10.00 Gy (five [18%

125 resulting in a decrease in the percentage of neonatal death attributable to SGA.

126 premature births, small full-term births, or neonatal deaths between the 3 groups.

127 APOs included fetal or neonatal death; birth before 36 weeks due to placental i

128 r and pancreatic beta cells are rescued from neonatal death, but develop lipoatrophic diabetes and di

129 Boys have a higher biological risk of neonatal death, but girls often have a higher social ris

130 newborns against preterm delivery and early neonatal death, but the impact beyond the neonatal perio

131 We have rescued the PTHrP-knockout mice from neonatal death by transgenic expression of PTHrP targete

132 to reduce maternal deaths, stillbirths, and neonatal deaths by 2025 in all countries tested.

133 rage of essential interventions would reduce neonatal deaths by an estimated 71%, benefit women and c

134 nnual number of stillbirths by up to 64,000, neonatal deaths by up to 25,000, and annual incidence of

135 e primary outcome measure was a composite of neonatal death, chronic lung disease, or major cerebral

136 l age had just three times the likelihood of neonatal death compared to babies born term, (OR 3.2 [95

137 mpact of universal screening on stillbirths, neonatal deaths, congenital syphilis, and disability-adj

138 abnormal renal arterial tree patterning and neonatal death consistent with kidney dysfunction.

139 cent achievements to reduce child mortality, neonatal deaths continue to remain high, accounting for

140 lowest HDI, 61% of all maternal, fetal, and neonatal deaths could be prevented.

141 Mice that escape neonatal death develop abnormal chemoresponsiveness as a

142 rence 0.3%, 95% CI -0.8 to 1.5; p=0.566) and neonatal deaths did not differ significantly between gro

143 ratory system, loss of Hoxa5 function causes neonatal death due to respiratory distress.

144 infants to assess which test best predicted neonatal death during the first 28 days after birth.

145 The early neonatal death (ENND) rate declined 12% between 1996 and

146 However, the relative risk of neonatal death following a preeclamptic pregnancy has no

147 icant reduction from baseline in the rate of neonatal death from all causes in the 7 days after birth

148 on is about double the risk of stillbirth or neonatal death from intrapartum uterine rupture.

149 As an estimated 23% of neonatal deaths globally are due to infectious causes, m

150 up to 15% of an estimated 3.3 million annual neonatal deaths globally.

151 Three-quarters of neonatal deaths happen in the first week--the highest ri

152 d encourage reappraisal of care during which neonatal death has occurred.

153 grams of even the most severe outcome, fetal/neonatal death, has led to a lack of understanding about

154 Although almost half of all neonatal deaths identified met minimum IDS criteria, mos

155 ated the absolute reductions in maternal and neonatal deaths if countries with low CDR increased thei

156 ience a considerably increased likelihood of neonatal death in East Africa.

157 ous substances on Earth and a major cause of neonatal death in nonvaccinated areas.

158 y affecting skeletal muscles that results in neonatal death in severe cases as a result of associated

159 hether maternal obesity is a risk factor for neonatal death in sub-Saharan Africa and the effect on t

160 The risk of neonatal death in term infants with five-minute Apgar sc

161 The rate of neonatal death in the 7 days after birth did not decreas

162 ters, there was no reduction in the rates of neonatal death in the 7 days after birth, stillbirth, or

163 The primary outcome was neonatal death in the first 7 days after birth.

164 ge, termination of pregnancy, stillbirth, or neonatal death in the metformin group (n=7) versus the p

165 changes affecting the risk of stillbirth and neonatal death in the offspring of men exposed to gonada

166 We calculated maternal and neonatal deaths in 2013 and 2012, respectively, for coun

167 uced litter size, and increased incidence of neonatal deaths in offspring.

168 There were 230 neonatal deaths in the Newhints zones compared with 252

169 le logistic regression to assess the risk of neonatal death (in women's most recent singleton livebir

170 ow the 75th percentile, however, the rate of neonatal death increased from 0.03 percent in the refere

171 We excluded stillbirths and neonatal deaths, infants whose mothers died, those with

172 The risk of early neonatal death is very high across a range of countries

173 Early success in averting neonatal deaths is possible in settings with high mortal

174 The maximum effect on neonatal deaths is through interventions delivered durin

175 cy increases the incidence of stillbirth and neonatal death, leads to structural defects in the place

176 Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine

177 cy were prospectively related to fetal loss, neonatal death, low birth weight, preterm birth, and MTC

178 percentile of weight for gestational age) or neonatal death (<28 days from delivery), and any severe

179 here were no stillbirths and fewer than five neonatal deaths (<2.7%) in affected pregnancies compared

180 nsent (2%), a test was not done due to early neonatal death (n=13), mother departing before venesecti

181 (both in the Foley catheter group) and eight neonatal deaths (n=5 in the misoprostol group and n=3 in

182 ed ovum, n=1; intrauterine death, n=2; early neonatal death, n=1; and neonatal death, n=2).

183 e death, n=2; early neonatal death, n=1; and neonatal death, n=2).

184 ers is essential to achieve the reduction in neonatal deaths needed to meet the Millennium Developmen

185 range of adverse outcomes including fetal or neonatal death, neurodisability, and lifelong risks to t

186 (PTD), small for gestational age (SGA), and neonatal death (NND).

187 all-for-gestational-age births, or fetal and neonatal deaths; nor did it increase urolithiasis during

188 of pregnancies; fetal death occurred in 4%, neonatal death occurred in 1%, preterm delivery occurred

189 One neonatal death occurred.

190 Stillbirths and neonatal deaths occurred among 7 MRI-exposed vs 9844 une

191 l and 1 117 257 (95% CI 1 033 611-1 200 902) neonatal deaths occurred in 45 countries with low CDRs i

192 52% of 87 neonatal deaths occurred in preterm or small for gestati

193 1.00 million (36.3%) of all neonatal deaths occurred on day 0 (uncertainty range 0.9

194 n exposed to this strategy, an excess of 3.5 neonatal deaths occurred, and the risk of maternal infec

195 12 fetuses (2%) died in utero and 27 (6%) neonatal deaths occurred.

196 al obesity was a significant risk factor for neonatal deaths occurring during the first 2 days of lif

197 s <1 month of age, with approximately 86% of neonatal deaths occurring in low- and lower-middle-incom

198 these results suggest an explanation for the neonatal death of homozygous Lc animals.

199 ound metabolic disorder that resulted in the neonatal deaths of numerous siblings.

200 in enlargement, hyperactivation of mTOR, and neonatal death on P0 due to reduced pup-maternal interac

201 .21, 0.77; P = 0.005) but was also shown for neonatal deaths on days 1-30 of life (aHR: 0.69; 95% CI:

202 ly decrease or increase the risk of fetal or neonatal death or serious neonatal morbidity, as compare

203 primary outcome was a composite of fetal or neonatal death or serious neonatal morbidity, with the f

204 primary outcome was a composite of fetal or neonatal death or the need for placement of a cerebrospi

205 ere subfertile with small litters and higher neonatal death (P < 0.02).

206 ficantly lower in the intervention arm (21.3 neonatal deaths per 1000 live births vs 30.1 per 1000 in

207 elated inequality increased by more than 1.5 neonatal deaths per 1000 livebirths per year in Ethiopia

208 th distribution was reduced by more than two neonatal deaths per 1000 livebirths per year.

209 s per 1000 total births, and no more than 10 neonatal deaths per 1000 livebirths, compatible with the

210 eaths per 1000 pregnancies and 2.4 (0.7-4.1) neonatal deaths per 1000 livebirths.

211 eaths per 1000 pregnancies and 2.3 (0.9-3.7) neonatal deaths per 1000 livebirths.

212 0,396 deaths) to estimate the proportions of neonatal deaths per day and used bootstrap sampling to d

213 Neonatal death, preterm birth, and pregnancy loss occurr

214 ficient for rescuing Insr knockout mice from neonatal death, preventing diabetes ketoacidosis, and no

215 rescues insulin receptor knockout mice from neonatal death, prevents diabetes in a majority of anima

216 Consequently, a higher neonatal death rate (57.1%) in hUGT1/Tlr2(-/-) mice was

217 ed in respiratory dysfunction and invariable neonatal death, related to the complete absence of matur

218 762-163 513 and 279 584-803 129 maternal and neonatal deaths, respectively.

219 chanical ventilation >/=24 h, stillbirth, or neonatal death); respiratory distress syndrome; any mech

220 Among the live births, there were 59 neonatal deaths, seven postneonatal deaths (first 28 day

221 s the rate of a composite primary outcome of neonatal death, severe intraventricular haemorrhage (IVH

222 National aims to reduce neonatal deaths should be set, and interventions incorpo

223 interval (CI): 1.38, 1.54 (n = 57 studies)), neonatal death (sRR = 1.22, 95% CI: 1.14, 1.30 (n = 28))

224 e disease in ruminants, in which it leads to neonatal death, the human disease phenotype is generally

225 ristics associated with an increased risk of neonatal death, the rate was lower in the regions with 4

226 In 2010, due to a pertussis outbreak and neonatal deaths, the California Department of Health rec

227 goal of reducing the numbers of maternal and neonatal deaths, the Government of India launched Janani

228 ficantly increased the risk of stillbirth or neonatal death (three [4%] of 69, 4.7 [1.2-19.0]).

229 erity of renal disease, which can range from neonatal death to adequate function into old age, charac

230 Adverse events included neonatal death (two in the standard care group and three

231 death, defined as intrapartum stillbirth or neonatal death unrelated to congenital anomaly, compared

232 d related these to the risk of stillbirth or neonatal death using Poisson regression analysis.

233 The risk of stillbirth or neonatal death was 1.7% versus 0.7% (odds ratio, 2.39; 9

234 The odds ratio for neonatal death was 2.81 (95% CI: 0.73, 10.8).

235 The rate of neonatal death was similar between groups (2.54 vs 2.21

236 adiation and malformations, stillbirths, and neonatal deaths was not seen in the children of female s

237 The corresponding ORs for neonatal death were 0.89 (95% CI, 0.58-1.39; P = .62) fo

238 ate that 3900 early-onset infections and 200 neonatal deaths were prevented in 1998 by the use of int

239 hs, 5,470 cases of low birth weight, and 430 neonatal deaths were prevented.

240 482 neonatal deaths were recorded.

241 Combined fetal loss and neonatal deaths were reduced by 11% (RR 0.89, 0.81-1.00,

242 mutations resulted in severe phenotypes with neonatal death, whereas missense changes resulted in imp

243 and palate (one), microtia alone (one), and neonatal death with multiple malformations (one).

244 Sepsis is the third most common cause of neonatal death, with Group B Streptococcus (GBS) being t

245 weeks' gestation, are at the highest risk of neonatal death, with ongoing post-neonatal mortality ris

246 s that generated funds for transport reduced neonatal deaths, with the largest effect seen in India (

247 ster MRI exposure, the risk of stillbirth or neonatal death within 28 days of birth and any congenita

248 an section, Apgar score <7 at 5 minutes, and neonatal death within 28 days.

249 or mechanical ventilation) or stillbirth or neonatal death within 72 hours after delivery.

250 Preterm birth (PTB) is a leading cause of neonatal death worldwide.

251 The 2.9 million annual neonatal deaths worldwide are attributable to three main

252 While information about 4 million neonatal deaths worldwide is limited, even less informat

253 rventions could avert an estimated 41-72% of neonatal deaths worldwide.

254 bor and infections are the leading causes of neonatal deaths worldwide.

255 infections remain one of the main causes of neonatal deaths worldwide.